J
688076
vs
MRK
J
688076
MRK
Over the past 12 months, Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd has underperformed MRK, delivering a return of +4% compared to the MRK's +52% growth.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
688076
MRK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
J
Intrinsic Value
37.57
CNY
Undervaluation 18%
MRK
Intrinsic Value
112.3437
USD
Overvaluation 5%
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
|
30.7
CNY
|
|||||
|
Merck & Co Inc
NYSE:MRK
|
118.3891
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
688076, MRK
688076, MRK
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Merck & Co Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
688076, MRK
688076, MRK
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
|
|||||||||
|
|
Merck & Co Inc
NYSE:MRK
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
66.6%
MRK
81.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Operating Margin
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
30.9%
MRK
41.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Net Margin
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
26.3%
MRK
28.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
FCF Margin
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
-49.8%
MRK
19%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROE
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
17.4%
MRK
36.9%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROA
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
9%
MRK
14.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROIC
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
12.5%
MRK
21.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
ROCE
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
15.4%
MRK
27.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
J
|
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd | ||||
|
|
Merck & Co Inc | ||||
Solvency Comparison
J
Jiangsu Sinopep Allsino Biopharm...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
688076, MRK
688076, MRK
Performance By Year
688076, MRK
688076, MRK
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 688076 to other stocks
LLY
Eli Lilly and Co
More expensive
vs Jiangsu Sinopep Allsino Biopha...
JNJ
Johnson & Johnson
More expensive
vs Jiangsu Sinopep Allsino Biopha...
AZN
AstraZeneca PLC
More expensive
vs Jiangsu Sinopep Allsino Biopha...
ROG
Roche Holding AG
Cheaper
vs Jiangsu Sinopep Allsino Biopha...
Select Stock to Compare
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
